Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Hillert

Showing results (131-140 of 306) with videos related to

Pageof 31
Sort By:
Frontiers in Immunology|March 21, 2022
Smoking Attributable Risk in Multiple SclerosisAli Manouchehrinia, Jesse Huang, Jan Hillert, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 2023
Association between clinic-level quality of care and patient-level outcomes in multiple sclerosisAnna H He, Ali Manouchehrinia, Anna Glaser, et al.
Annals of Neurology|January 5, 2022
Reduction in Cognitive Processing Speed Surrounding Multiple Sclerosis RelapseKyla A McKay, Sahl K Bedri, Ali Manouchehrinia, et al.
JAMA Network Open|December 1, 2021
Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in SwedenKyla A McKay, Fredrik Piehl, Simon Englund, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2013
Smoking and risk of treatment-induced neutralizing antibodies to interferon β-1aAnna Karin Hedström, Malin Ryner, Katarina Fink, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 3, 2019
Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort studyLoes Crielaard, Andrius Kavaliunas, Ryan Ramanujam, et al.
BMJ Open|July 14, 2019
Earnings among people with multiple sclerosis compared to references, in total and by educational level and type of occupation: a population-based cohort study at different points in timeMichael Wiberg, Chantelle Murley, Petter Tinghög, et al.
Annals of Clinical and Translational Neurology|May 13, 2022
Copy number variations across the blood-brain barrier in multiple sclerosisSahl Khalid Bedri, Björn Evertsson, Mohsen Khademi, et al.
BMJ Open|May 16, 2023
Disease-modifying therapies and cost-of-illness progression among people newly diagnosed with multiple sclerosis: a national register-based cohort study covering treatment initiation with interferons, glatiramer acetate or natalizumabKorinna Karampampa, Hanna Gyllensten, Emilie Friberg, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 2, 2022
Comparison of employment among people with Multiple Sclerosis across EuropeDavid Ellenberger, Tina Parciak, Waldemar Brola, et al.
Pageof 31

Showing results (131-140 of 306) with videos related to

Sort By:
Pageof 31
Frontiers in Immunology|March 21, 2022
Smoking Attributable Risk in Multiple SclerosisAli Manouchehrinia, Jesse Huang, Jan Hillert, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 2023
Association between clinic-level quality of care and patient-level outcomes in multiple sclerosisAnna H He, Ali Manouchehrinia, Anna Glaser, et al.
Annals of Neurology|January 5, 2022
Reduction in Cognitive Processing Speed Surrounding Multiple Sclerosis RelapseKyla A McKay, Sahl K Bedri, Ali Manouchehrinia, et al.
JAMA Network Open|December 1, 2021
Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in SwedenKyla A McKay, Fredrik Piehl, Simon Englund, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2013
Smoking and risk of treatment-induced neutralizing antibodies to interferon β-1aAnna Karin Hedström, Malin Ryner, Katarina Fink, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 3, 2019
Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort studyLoes Crielaard, Andrius Kavaliunas, Ryan Ramanujam, et al.
BMJ Open|July 14, 2019
Earnings among people with multiple sclerosis compared to references, in total and by educational level and type of occupation: a population-based cohort study at different points in timeMichael Wiberg, Chantelle Murley, Petter Tinghög, et al.
Annals of Clinical and Translational Neurology|May 13, 2022
Copy number variations across the blood-brain barrier in multiple sclerosisSahl Khalid Bedri, Björn Evertsson, Mohsen Khademi, et al.
BMJ Open|May 16, 2023
Disease-modifying therapies and cost-of-illness progression among people newly diagnosed with multiple sclerosis: a national register-based cohort study covering treatment initiation with interferons, glatiramer acetate or natalizumabKorinna Karampampa, Hanna Gyllensten, Emilie Friberg, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 2, 2022
Comparison of employment among people with Multiple Sclerosis across EuropeDavid Ellenberger, Tina Parciak, Waldemar Brola, et al.
Pageof 31